Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Certara Inc (NQ: CERT )

15.95 -0.26 (-1.60%)
Streaming Delayed Price Updated: 3:40 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 413,493
Open 16.24
Bid (Size) 15.93 (2)
Ask (Size) 15.95 (2)
Prev. Close 16.21
Today's Range 15.83 - 16.34
52wk Range 11.81 - 24.96
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
From Certara
Via GlobeNewswire
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
From Certara
Via GlobeNewswire

Performance

YTD
-8.07%
-8.07%
1 Month
-13.92%
-13.92%
3 Month
+0.89%
+0.89%
6 Month
+16.00%
+16.00%
1 Year
-34.95%
-34.95%

More News

Read More
Decoding 4 Analyst Evaluations For Certara
Via Benzinga
Analyst Scoreboard: 4 Ratings For Certara
Via Benzinga
Certara Reports Fourth Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Earnings Scheduled For February 29, 2024
Via Benzinga
Recap: Certara Q3 Earnings
Via Benzinga
The Latest Analyst Ratings for Certara
Via Benzinga
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference
From Certara
Via GlobeNewswire
Tax Season Is Here: Meet The New Federal Program That Can Eat Away At Tax Preparation Companies
Via Benzinga
Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies
From Certara
Via GlobeNewswire
The Latest Analyst Ratings for Certara
Via Benzinga
Looking Into Certara's Return On Capital Employed
Via Benzinga
Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development
From Certara
Via GlobeNewswire
Certara Reports Third Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference
From Certara
Via GlobeNewswire
Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software
From Certara
Via GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
From Certara
Via GlobeNewswire
Certara Simcyp™ Group Awarded Two New Grants from US FDA
From Certara
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Certara Reports Second Quarter 2023 Financial Results
From Certara
Via GlobeNewswire
Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023
From Certara
Via GlobeNewswire
Certara to Participate in the Jefferies Global Healthcare Conference
From Certara
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.